BIOA BioAge Labs, Inc.
Healthcare · Market cap: $254.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $43.6M | $0 |
| 2024-Q4 | $4.3M | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $918.1K |
| 2026-Q1 | $0 | $5.1M |
| 2026-Q2 | $0 | $1.7M |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$47.9M9 buy days
Sold$7.8M10 sell days
Net insider flow+$40.1Mnet buying · 5 years
Latest trade2026-06-30Barton Shane
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Sell | Barton Shane | Other officer | 20,216 | $25.19 | $509.2K | 1 |
| 2026-06-29 | Sell | Barton Shane | Other officer | 42,350 | $25.21 | $1.1M | 1 |
| 2026-04-01 | Sell | RUBIN PAUL D | Other C-suite | 8,820 | $17.81 | $157.1K | 1 |
| 2026-03-02 | Sell | RUBIN PAUL D | Other C-suite | 7,433 | $20.30 | $150.9K | 1 |
| 2026-02-02 | Sell | RUBIN PAUL D | Other C-suite | 7,433 | $18.75 | $139.4K | 1 |
| 2026-01-13 | Sell | Fortney Kristen | CEO | 233,107 | $18.12 | $4.2M | 1 |
| 2026-01-13 | Sell | GOLDSTEIN DOV A MD | CFO | 27,000 | $19.70 | $531.8K | 4 |
| 2026-01-02 | Sell | RUBIN PAUL D | Other C-suite | 7,433 | $12.85 | $95.5K | 1 |
| 2025-12-09 | Sell | RUBIN PAUL D | Other C-suite | 18,000 | $12.00 | $216.0K | 1 |
| 2025-12-04 | Sell | RUBIN PAUL D | Other C-suite | 68,897 | $10.19 | $702.1K | 1 |
| 2024-10-03 | Buy | Pande Vijay Satyanand | Director | 25,306 | $19.90 | $503.6K | 1 |
| 2024-10-02 | Buy | Pande Vijay Satyanand | Director | 67,096 | $19.73 | $1.3M | 1 |
| 2024-10-01 | Buy | Pande Vijay Satyanand | Director | 126,793 | $19.73 | $2.5M | 1 |
| 2024-09-27 | Buy | Pande Vijay Satyanand | Director | 900,000 | $18.00 | $16.2M | 1 |
| 2024-09-27 | Buy | HEALY JAMES | Director | 666,665 | $18.00 | $12.0M | 5 |
| 2024-09-27 | Buy | Cormorant Asset Management, LP | Other | 450,000 | $18.00 | $8.1M | 1 |
| 2024-09-27 | Buy | ENRIGHT PATRICK G | Director | 400,000 | $18.00 | $7.2M | 1 |
| 2024-09-27 | Buy | Hemrajani Rekha | Director | 3,000 | $18.00 | $54.0K | 1 |
| 2024-09-27 | Buy | Barton Shane | Other officer | 2,632 | $18.00 | $47.4K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Pande Vijay Satyanand | Director | $20.5M | $0 | 2024-10-03 |
| HEALY JAMES | Director | $12.0M | $0 | 2024-09-27 |
| Cormorant Asset Management, LP | Other | $8.1M | $0 | 2024-09-27 |
| ENRIGHT PATRICK G | Director | $7.2M | $0 | 2024-09-27 |
| Fortney Kristen | CEO | $0 | $4.2M | 2026-01-13 |
| Barton Shane | Other officer | $47.4K | $1.6M | 2026-06-30 |
| RUBIN PAUL D | Other C-suite | $0 | $1.5M | 2026-04-01 |
| GOLDSTEIN DOV A MD | CFO | $0 | $531.8K | 2026-01-13 |
| Hemrajani Rekha | Director | $54.0K | $0 | 2024-09-27 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-09-27 → 2024-10-03 | 6 | $47.9M | 48 | +9.8% (+11.8% raw) | -78.3% (-74.8% raw) | -84.1% (-84.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.